Hidradenitis suppurativa treated with finasteride

Journal of Dermatological Treatment

Volumn 16, Issue 2, 2005, Pages 75-78

  Joseph, Mary Augustine ^a   Jayaseelan, E ^a   Ganapathi, B ^a   Stephen, John ^a  

^a ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

Finasteride; Hidradenitis suppurativa

Indexed keywords

ANDROSTANOLONE; CYPROTERONE ACETATE; ERYTHROMYCIN; ESTROGEN; ETRETIN; FINASTERIDE; ISOTRETINOIN; RETINOID; STEROID 5ALPHA REDUCTASE; STEROID 5ALPHA REDUCTASE INHIBITOR; TESTOSTERONE; TETRACYCLINE;

ADOLESCENT; ADULT; ARTICLE; BREAST HYPERTROPHY; BREAST TENDERNESS; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FOLLOW UP; GYNECOMASTIA; HEADACHE; HORMONAL REGULATION; HUMAN; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; REFRACTORY PERIOD; REMISSION; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; SUPPURATIVE HIDRADENITIS; WEIGHT GAIN; WOUND HEALING;

ADOLESCENT; ADULT; ENZYME INHIBITORS; FEMALE; FINASTERIDE; FOLLOW-UP STUDIES; HIDRADENITIS SUPPURATIVA; HUMANS; MALE; TESTOSTERONE 5-ALPHA-REDUCTASE; TIME FACTORS; TREATMENT OUTCOME;

EID: 18744374921     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/09546630510031403     Document Type: Article

References (14)

1. Mortimer PS, Dawber RPR, Gales MA, Moore RA. A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol. 1986;115:263-8.
2. Hogan DJ, Light MJ. Successful treatment of hidradenitis suppurativa with acitretin. J Am Acad Dermatol. 1998;19: 355-6.
3. Boer J, van Gemert MJP. Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. J Am Acad Dermatol. 1999;40:73-6.
4. Barth JH, Layton AM, Cunliffe WJ. Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa. Br J Dermatol. 1996;134:1057-9.
5. Carmen CW, Cook MG. Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands. Br J Dermatol. 1990;122:763-9.
6. Eicheler W, Dreher M, Hoffmann R, Happle R, Aumuller G. Immunohistochemical evidence for differential distribution of 5α-reductase isoenzymes in human skin. Br J Dermatol. 1995;133:371-6.
7. Farrell AM, Randall VA, Vafaee T, Dawber RPR. Finasteride as a therapy for hidradenitis suppurativa (letter). Br J Dermatol. 1999;141:1138-9.
8. McClellan KJ, Markham A. Finasteride: A review of its use in male pattern hair loss. Drugs. 1999;57(I):111-26.
9. Roberts JL, Fiedler V, Imperato-McGinley J, Whiting D, Olsen E, Shupack J, et al. Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss. J Am Acad Dermatol. 1999;41:555-63.
10. James WO, Vivan LF, John G, Stuart SH. Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol. 1999;162:1295-300.
11. Hershlag A, Peterson CM. Endocrine disorders. In: Jonathan SB, editor. Novak's gynecology. 13th ed. Philadelphia: Lippincott Williams & Wilkins; 2002. p 871-930.
12. Venturoli S, Marescalchi O, Colombo FM, Macrelli S, Ravaioli B, Bagnoli A, et al. A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole and cyproterone acetate-estrogen regimens in the treatment of hirsutism. J Clin Endocrinol Metab. 1999;84:1304-10.
13. Smith CG, Franks S. Hirsutism In: John AHW, Stephen MS, editors. Oxford textbook of endocrinology and diabetology. New York: Oxford University Press; 2002. p 1148-59.
14. Lanh G, Diane KW, Jean LF. Gynecomastia and breast cancer during finasteride therapy (letter). N Engl J Med. 1996;335:823.